Teknova Provides Strategic Business Update and Announces Preliminary Second Quarter 2024 Results

Company reaffirms 2024 revenue guidance of $35-38 million Business and Financial Updates Clinical Solutions: Teknova has seen an increase in the number of Clinical Solutions customers since fiscal 2023, from 34 to 43. While the Company's overall revenue in fiscal 2024 is expected to be lower within the Clinical Solutions category compared to fiscal 2023, Teknova has successfully grown the number of its customers entering clinical trials and ordering its GMP-grade products, supporting the Company's thesis th ...